Barclays Maintains an 'Overweight' on Dun & Bradstreet (DNB); Asking The Tough Questions
Tweet
Share
E-mailGet Alerts DNB Hot Sheet
Price: $9.31 +1.31%
Rating Summary:
10 Buy, 8 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Rating Summary:
10 Buy, 8 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Join SI Premium – FREE
Barclays maintains an 'Overweight' on Dun & Bradstreet (NYSE: DNB) price target lowered from $92 to $80.
Analyst, Manav Patnaik, said, "DNB is economically sensitive and 1Q12 showed it. The impact on the shares, while might seem overdone, was likely deserved as (1) its core North America (N.A.) Risk management (RMS) business was the area of weakness and (2) the company still does not have a clear path of new product innovation to reinvigorate this unit (at least not in 2012)."
Patnaik did however, bring up a critical point to DNB management...is the company better off private? Patnaik believes opportunities exist for the company, but feels DNB management need to re-assess valuation, calling this 're-assessment' the barrier to a sale.
FY12 EPS estimates are lowered from $6.51 to $6.43, but FY13 are raised from $7.16 to $7.25.
In the end, the Barclays analyst, said that any investor with a long-term time horizon, may consider accumulating shares at current levels.
For an analyst ratings summary and ratings history on Dun & Bradstreet click here. For more ratings news on Dun & Bradstreet click here.
Shares of Dun & Bradstreet closed at $63.34 yesterday.
Analyst, Manav Patnaik, said, "DNB is economically sensitive and 1Q12 showed it. The impact on the shares, while might seem overdone, was likely deserved as (1) its core North America (N.A.) Risk management (RMS) business was the area of weakness and (2) the company still does not have a clear path of new product innovation to reinvigorate this unit (at least not in 2012)."
Patnaik did however, bring up a critical point to DNB management...is the company better off private? Patnaik believes opportunities exist for the company, but feels DNB management need to re-assess valuation, calling this 're-assessment' the barrier to a sale.
FY12 EPS estimates are lowered from $6.51 to $6.43, but FY13 are raised from $7.16 to $7.25.
In the end, the Barclays analyst, said that any investor with a long-term time horizon, may consider accumulating shares at current levels.
For an analyst ratings summary and ratings history on Dun & Bradstreet click here. For more ratings news on Dun & Bradstreet click here.
Shares of Dun & Bradstreet closed at $63.34 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fiserv (FI) PT Raised to $175 at TD Cowen
- GameSquare Holdings Inc (GAME) PT Lowered to $5 at Roth/MKM
- Spotify (SPOT) PT Raised to $345 at Macquarie
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
